Cosciens Biopharma logo

Cosciens Biopharma Share Price Today

(NASDAQ: CSCI)

Cosciens Biopharma share price is $2.78 & ₹241.77 as on 6 Mar 2025, 2.30 'hrs' IST

$2.78

0.08

(2.96%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Cosciens Biopharma share price in Dollar and Rupees. Guide to invest in Cosciens Biopharma stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Cosciens Biopharma, along with analyst recommendations, forecasts, and comprehensive financials.

Cosciens Biopharma share price movements

  • Today's Low: $2.70
    Today's High: $2.87

    Day's Volatility :5.92%

  • 52 Weeks Low: $2.38
    52 Weeks High: $6.77

    52 Weeks Volatility :64.86%

Cosciens Biopharma (CSCI) Returns

PeriodCosciens Biopharma IncIndex (Russel 2000)
3 Months
-3.35%
0.0%
6 Months
-30.5%
0.0%
1 Year
-54.72%
0.0%
3 Years
-54.72%
-11.6%

Cosciens Biopharma (CSCI) Key Statistics

in dollars & INR

Previous Close
$2.7
Open
$2.75
Today's High
$2.87
Today's Low
$2.7
Market Capitalization
$13.1M
Today's Volume
$4.7K
52 Week High
$6.7738
52 Week Low
$2.38
Revenue TTM
$4.9M
EBITDA
$-18.0M
Earnings Per Share (EPS)
$-2.69
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-65.92%

How to invest in Cosciens Biopharma Stock (CSCI) from India?

It is very easy for Indian residents to invest directly in Cosciens Biopharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cosciens Biopharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cosciens Biopharma or CSCI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cosciens Biopharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cosciens Biopharma shares which would translate to 0.313 fractional shares of Cosciens Biopharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cosciens Biopharma, in just a few clicks!

Returns in Cosciens Biopharma (CSCI) for Indian investors in Rupees

The Cosciens Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cosciens Biopharma investment value today

Current value as on today

₹50,226

Returns

₹49,774

(-49.77%)

Returns from Cosciens Biopharma Stock

₹54,723 (-54.72%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Cosciens Biopharma (CSCI)

-56%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Cosciens Biopharma Stock from India on INDmoney has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Cosciens Biopharma

Insights on Cosciens Biopharma Stock (Ticker Symbol: CSCI)

  • Price Movement

    In the last 1 month, CSCI stock has moved up by 4.1%

Cosciens Biopharma Technicals Summary

Sell

Neutral

Buy

Cosciens Biopharma is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Cosciens Biopharma (CSCI) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cosciens Biopharma Inc logo
-3.14%
-30.5%
-54.72%
-54.72%
-54.72%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cosciens Biopharma Inc logo
NA
NA
NA
0.0
-0.66
-0.23
NA
8.57
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cosciens Biopharma Inc logo
NA
$13.1M
-54.72%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Cosciens Biopharma

COSCIENS Biopharma Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests in Canada, Switzerland, Ireland, Denmark, Germany, the United States, and internationally. Its lead product is Macrilen (macimorelin), an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of patients with adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as endocrinology and oncology indications; AEZS-150, a delayed clearance parathyroid hormone fusion polypeptide that is in preclinical trial for the treatment of chronic hypoparathyroidism; and AEZS-130 that is in preclinical trial for the treatment of amyotrophic lateral sclerosis. The company also has a license and research agreement with University of Wuerzburg to develop, manufacture, and commercialize AIM biologicals for the treatment of neuromyelitis optica spectrum disorder; and for pre-clinical development towards the potential treatment of Parkinson's disease. In addition, it has a license agreement with Consilient Health Ltd. and NK MEDITECH Ltd. for the development and commercialization of macimorelin; a distribution and commercialization agreement with Er-Kim Pharmaceuticals Bulgaria Eood for the commercialization of macimorelin for the diagnosis of growth hormone deficiency in children and adults; as well as The University of Sheffield, the United Kingdom for the development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of chronic hypoparathyroidism. The company was formerly known as Aeterna Zentaris Inc. and changed its name to COSCIENS Biopharma Inc. in August 2024. COSCIENS Biopharma Inc. was incorporated in 1990 and is headquartered in Toronto, Canada.
Organization
Cosciens Biopharma
Employees
0
CEO
Mr. Gilles R. Gagnon ICD.D, M.B.A., M.Sc.
Industry
Miscellaneous

Management People of Cosciens Biopharma

NameTitle
Mr. Gilles R. Gagnon ICD.D, M.B.A., M.Sc.
President, CEO & Director
Mr. Giuliano La Fratta
Senior VP of Finance & CFO
Dr. Michael Teifel Ph.D.
Senior VP of Non-Clinical Development & Chief Scientific Officer
Dr. Nicola Ammer M.D.
Chief Medical Officer & Senior VP of Clinical Development
Dr. Matthias Gerlach
Senior Vice President Manufacturing and Supply Chain & Head of Production

Important FAQs about investing in CSCI Stock from India :

What is Cosciens Biopharma share price today?

Cosciens Biopharma share price today stands at $2.78, Open: $2.75 ; Previous Close: $2.70 ; High: $2.87 ; Low: $2.70 ; 52 Week High: $6.77 ; 52 Week Low: $2.38.

The stock opens at $2.75, after a previous close of $2.70. The stock reached a daily high of $2.87 and a low of $2.70, with a 52-week high of $6.77 and a 52-week low of $2.38.

Can Indians buy Cosciens Biopharma shares?

Yes, Indians can invest in the Cosciens Biopharma (CSCI) from India.

With INDmoney, you can buy Cosciens Biopharma at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Cosciens Biopharma at zero transaction cost.

How can I buy Cosciens Biopharma shares from India?

It is very easy to buy Cosciens Biopharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cosciens Biopharma (CSCI) be purchased?

Yes, you can buy fractional shares of Cosciens Biopharma with INDmoney app.

What are the documents required to start investing in Cosciens Biopharma stocks?

To start investing in Cosciens Biopharma, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Cosciens Biopharma Stock (CSCI)?

Today’s highest price of Cosciens Biopharma (CSCI) is $2.87.

Today’s lowest price of Cosciens Biopharma (CSCI) is $2.70.

What is today's market capitalisation of Cosciens Biopharma?

Today's market capitalisation of Cosciens Biopharma CSCI is 13.1M

What is the 52 Week High and Low Range of Cosciens Biopharma Stock (CSCI)?

  • 52 Week High

    $6.77

  • 52 Week Low

    $2.38

What are the historical returns of Cosciens Biopharma (CSCI)?

  • 1 Month Returns

    -3.14%

  • 3 Months Returns

    -30.5%

  • 1 Year Returns

    -54.72%

  • 5 Years Returns

    -54.72%

Who is the Chief Executive Officer (CEO) of Cosciens Biopharma ?

Mr. Gilles R. Gagnon ICD.D, M.B.A., M.Sc. is the current Chief Executive Officer (CEO) of Cosciens Biopharma.